Business · 17/05/2002Updated: 10/17/2026 · 1 min read
FDA Withdraws Draft Guidance on Topical Dermatological Drug Products
Summary
The FDA has withdrawn its draft guidance on topical dermatological drug products, following public comments and consideration by advisory committees.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →